{"id":4474,"date":"2020-08-26T09:20:23","date_gmt":"2020-08-26T09:20:23","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/cryptosporidium-giardia-enzyme-immunoassay\/"},"modified":"2021-01-08T11:29:35","modified_gmt":"2021-01-08T11:29:35","slug":"cryptosporidium-giardia-enzyme-immunoassay","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/cryptosporidium-giardia-enzyme-immunoassay\/","title":{"rendered":"Cryptosporidium\/Giardia enzyme immunoassay"},"content":{"rendered":"
Cryptosporidiosis is routinely diagnosed by microscopic analysis of stool samples using organic dyes, or by immunostaining with direct fluorescent antibody, and it can be difficult to detect. Similarly, Giardia<\/em> lamblia <\/em>infection is frequently misdiagnosed, relying on poorly performing antigen-based testing. A new enzyme immunoassay (EIA) for the qualitative detection of Cryptosporidium <\/em>and G. lamblia<\/em> antigens in human faecal specimens from patients displaying gastrointestinal symptoms, the Prolisa Cryptosporidium\/Giardia<\/em> EIA kit offers precise results with high sensitivity and excellent specificity, enabling accurate diagnosis of infection. This convenient, rapid and easy-to-use method of detecting Cryptosporidium <\/em>and G. lamblia<\/em> is supplied in a 96-well test size consisting of detachable stripwells. This assay uses monoclonal anti-Cryptosporidium<\/em> and anti-G. lamblia<\/em> antibodies to ensure excellent sensitivity and specificity for high value diagnostic results. It can be performed manually as well as on most automated platforms for increased workflow flexibility.
\n
\nSupplier:<\/strong> Pro-Lab Diagnostics
\nWebsite:<\/strong> <\/a><\/p>\n